This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...
This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc.
AutoGuide on MSN1h
The World Is Ready For A Mustang SedanA new trademark filing from Ford suggests the long-rumored four-door Mustang may finally be in the works. Ford recently filed ...
Windtree Therapeutics (WINT) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. application ...
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...
The US Patent and Trademark Office’s move to make it easier for administrative judges to turn away validity challenges swings ...
The Business Software Alliance said international alliances, export control regimes and standards harmonization efforts can ...
Some are using president Trump’s speech to highlight his administration's sweeping changes to the federal workforce.
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...
On February 28, 2025, the United States Patent and Trademark Office announced that it has rescinded the June 21, 2022, ...
This is Osteoboost’s 6th patent in the US. It is expected to launch in Q2 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback